Clinical Trials for Retinal Degeneration

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

NCT ID: NCT06789445

The CLARICO trial is a research study that is testing a new treatment called OpCT-001 for adults with specific eye conditions known as primary photoreceptor diseases, which include diseases like Re...

Rod and Cone Mediated Function in Retinal Disease

NCT ID: NCT02617966

This clinical trial is studying how well people can see in the dark and whether this can help doctors understand the severity of certain eye diseases, like retinal degeneration, retinitis pigmentos...

Cell Collection to Study Eye Diseases

NCT ID: NCT01432847

This clinical trial is focused on studying eye diseases that affect the retina, specifically Best Vitelliform Dystrophy (Best disease), Late-Onset Retinal Degeneration (L-ORD), and Age-Related Macu...

Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab

NCT ID: NCT06167642

A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema

NCT ID: NCT06305416

This clinical trial is studying the effectiveness and safety of a medication called Ranibizumab for treating diabetic macular edema (DME), a condition that can cause vision loss in people with diab...

Oral Metformin for Treatment of ABCA4 Retinopathy

NCT ID: NCT04545736

This clinical trial is studying whether an oral medication called metformin can be safe and help slow down vision loss in people with ABCA4 retinopathy, a genetic eye disease that can lead to signi...

Adaptive Optics Imaging of Outer Retinal Diseases

NCT ID: NCT05355415

This clinical trial, titled "Adaptive Optics Imaging of Outer Retinal Diseases," is focused on understanding and diagnosing various outer retinal diseases, such as age-related macular degeneration ...

A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection

NCT ID: NCT05921162

MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)

NCT ID: NCT06455826

The Wallaby trial is a research study looking at a new treatment called VP-001 for people with a specific genetic condition known as PRPF31 mutation-associated retinal dystrophy, which can lead to ...

A Study of Two Doses of VP-001 Administered Intravitreally in Participants with Confirmed PRPF31 Mutation-Associated Retinal Dystrophy Previously Treated with VP001

NCT ID: NCT06852963

This clinical trial is studying a treatment called VP-001 for people with a specific type of vision loss known as Retinitis Pigmentosa, which is caused by a mutation in the PRPF31 gene. The researc...

High Resolution, High-speed Multimodal Ophthalmic Imaging

NCT ID: NCT04129021

This clinical trial is exploring a new high-resolution and high-speed imaging system designed to take detailed pictures of the eye. It aims to improve our understanding of various eye conditions th...

Minocycline for Chronic Autoimmune Uveitis

NCT ID: NCT05474729

This clinical trial is studying the use of a medication called minocycline to treat patients with chronic autoimmune uveitis, a serious eye condition that can lead to vision loss due to persistent ...